Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

RSS NEWS FEED

Using Our Materials

---

Rules

Authors retain ownership of the copyright for all materials, but materials marked “Open Access” may be downloaded, reused, reprinted, modified, distributed, and/or copied, so long as the original source is cited. No permission is required.

For PharmedOut slideshows and factsheets, appropriate attribution can be provided by simply citing PharmedOut.org, Georgetown University Medical Center. For other Open Access materials, please cite the authors of those materials.

Our permissions policy is based on the Creative Commons Attribution License (summary.)

Requests

Rather than sending our materials to others, please direct people who want to view or use our materials to our website, so that we can keep track of how many times our materials are downloaded.

Although you’re not required to let us know, if you give a presentation using our slides, we would appreciate knowing where, when, and to whom. Feel free to share comments with us as well.

Pre and post-test evaluations are available for our slideshow; just contact us. If you use these with our presentation, please send us copies, as we are collating these data.

We may be able to provide PharmedOut pencils or post-it notes to distribute at presentations using our materials. Contact us about availability.

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

FDA to Advertise Fake Blood Pressure Pill
Will study consumer responses to safety warnings Pharmalot

---

New GAO Report
Prescription Drugs: FDA’s Oversight of the Promotion of Drugs for Off-Label Uses GAO

---

Teaching Doctors—or Selling to Them?
Industry backs away from CME Businessweek

---

Fatal Medication Errors at Home Rise Sharply
More mixed-drug overdoses WSJ

---

Why Not the Best?
U.S. Health System Scores 65 out of 100 The Commonwealth Fund (article in WP)

---

A Call for a Warning System on Artificial Joints
National registry needed NYT

---

Drugmaker Sponsors Journalism Group Seminar
Journalists get lunch from Novo and Lilly Pharmalot

---

Are Vaccine Defenders For Sale?
COIs in vaccine experts Pharmalot

---

FDA Staffers Start Dissident Website
Concerns about drug safety expressed Thoreau-FDA

---

Medicare Part D Was A ‘Windfall’ For Pharma
Shift from Medicaid jacks drug prices 30% Pharmalot

---

The Real War on Drugs
Compared to U.K., Americans pay double for drugs Pharmagossip

---

Commentary

Deceptive Market Practices in the Marketplace of Ideas
“Think tanks” distorting health care debate Bioethics Forum

---

Click HERE to read the entire news archives